How Pharma funded psychiatrists pathologize behavior as mental illness so more drugs can be marketed to the masses
Critics say there’s a damaging conflict of interest with the financial ties between drug companies and experts who are revising the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), as well as guidelines on the best treatments. This question has been a big topic of debate not just in scientific and academic journals it also concerns the public welfare.